Pharming (PHAR) Capital Expenditures (2020 - 2026)
Pharming (PHAR) recorded Capital Expenditures of -$321,000 in Q2 2026, compared with -$410,000 a year earlier.
Powered by 
Analysis
Pharming (PHAR) Capital Expenditures (2020 - 2026) Analysis & Trends
On a TTM basis, Pharming's Capital Expenditures came in at $1.96 million as of Jun 30, 2026, up 402.1% year-over-year; for FY2025, it came in at $749,000, down 6.4% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -30.6% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $800,000 in FY2024 (-44.3%), $1.44 million in FY2023 (+4.4%), $1.38 million in FY2022 (-87.2%) and $10.74 million in FY2021 (+130.6%).
- Quarterly Capital Expenditures has ranged from -$2.02 million in Q3 2021 to $2.57 million in Q4 2023 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Pharming | 927.62 Mn | 229.29 Mn | 102.20 | -42,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -42,000.00 |
| Jun 30, 2026 | -321,000.00 |
| Mar 31, 2026 | -238,000.00 |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 212,000.00 |
| Jun 30, 2025 | -410,000.00 |
| Mar 31, 2025 | -282,000.00 |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | -294,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | -147,000.00 |
| Jun 30, 2023 | -986,000.00 |
| Mar 31, 2023 | -215,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Sep 30, 2022 | -342,000.00 |
| Dec 31, 2021 | -1.96 Mn |
| Sep 30, 2021 | -2.02 Mn |
| Dec 31, 2020 | 6.53 Mn |
API Access
Pharming Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();